|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE3034001A1
(de)
|
1980-09-10 |
1982-04-22 |
Hoechst Ag, 6000 Frankfurt |
Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung
|
|
PL176081B1
(pl)
|
1995-06-06 |
1999-04-30 |
Politechnika Warszawska |
Sposób wytwarzania 3-aminoizochinoliny i jej N-mono oraz N,N-dipodstawionych pochodnych
|
|
EP1185509A2
(en)
|
1999-05-24 |
2002-03-13 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
US7199149B2
(en)
|
2003-10-01 |
2007-04-03 |
Bristol Myers Squibb Company |
Monocyclic and bicyclic lactams as factor Xa inhibitors
|
|
JP2007008816A
(ja)
|
2003-10-15 |
2007-01-18 |
Ube Ind Ltd |
新規イソキノリン誘導体
|
|
EP1657241A1
(en)
|
2004-11-03 |
2006-05-17 |
Schering Aktiengesellschaft |
Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
|
|
EP1655295A1
(en)
|
2004-11-03 |
2006-05-10 |
Schering Aktiengesellschaft |
Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
|
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
NZ565040A
(en)
*
|
2005-06-28 |
2010-05-28 |
Sanofi Aventis |
Isoquinoline derivatives as inhibitors of RHO-kinase
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
DOP2006000233A
(es)
|
2005-10-28 |
2007-06-15 |
Lilly Co Eli |
Inhibidores de cinasa
|
|
US7572809B2
(en)
|
2005-12-19 |
2009-08-11 |
Hoffmann-La Roche Inc. |
Isoquinoline aminopyrazole derivatives
|
|
MY149143A
(en)
|
2006-01-18 |
2013-07-15 |
Amgen Inc |
Thiazole compounds as protien kinase b (pkb) inhibitors
|
|
CA2651072A1
(en)
*
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
|
KR20090092303A
(ko)
*
|
2006-12-27 |
2009-08-31 |
사노피-아벤티스 |
사이클로알킬아민 치환된 이소퀴놀린 유도체
|
|
EP1975166A1
(en)
|
2007-03-30 |
2008-10-01 |
Bayer Schering Pharma AG |
Synthesis of anthranilamides
|
|
EP2008658A1
(en)
|
2007-06-28 |
2008-12-31 |
Bayer Schering Pharma Aktiengesellschaft |
Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
|
|
KR20100044251A
(ko)
|
2007-08-15 |
2010-04-29 |
싸이토키네틱스, 인코포레이티드 |
특정 화학 물질, 조성물 및 방법
|
|
GB0803018D0
(en)
*
|
2008-02-19 |
2008-03-26 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
GB0812969D0
(en)
*
|
2008-07-15 |
2008-08-20 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
WO2010098788A2
(en)
|
2008-08-25 |
2010-09-02 |
Amplimmune, Inc. |
Pd-i antagonists and methods for treating infectious disease
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
NZ628923A
(en)
|
2009-11-24 |
2016-02-26 |
Medimmune Ltd |
Targeted binding agents against b7-h1
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
DK2512474T3
(en)
|
2009-12-16 |
2014-12-01 |
Pfizer |
N-linked hydroxamic acid derivatives which can be used as antibacterial agents
|
|
CN104530079B
(zh)
|
2009-12-18 |
2017-10-20 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
BR112012024705A2
(pt)
|
2010-03-31 |
2016-06-07 |
Actelion Pharmaceuticals Ltd |
derivados antibacterianos de isoquinolin-3-ilureia
|
|
BR112013010310A2
(pt)
|
2010-10-29 |
2016-11-29 |
Pfizer |
inibidores de acetil-coa carboxilase de lactama n1/n2
|
|
TW201307292A
(zh)
|
2010-12-17 |
2013-02-16 |
Hoffmann La Roche |
經取代之６，６－稠合含氮雜環化合物及其用途
|
|
CA2830866A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
EA025266B1
(ru)
|
2011-06-23 |
2016-12-30 |
Ваймет Фармасьютикалс, Инк. |
Соединения, ингибирующие металлоферменты
|
|
WO2013003315A2
(en)
|
2011-06-26 |
2013-01-03 |
President And Fellows Of Harvard College |
Methods for preparing isoquinolines
|
|
WO2013169793A2
(en)
|
2012-05-09 |
2013-11-14 |
Ipierian, Inc. |
Methods and compositions for tdp-43 proteinopathies
|
|
AR092253A1
(es)
*
|
2012-08-27 |
2015-04-08 |
Array Biopharma Inc |
Inhibidores de serina/treonina cinasa
|
|
GB201216018D0
(en)
*
|
2012-09-07 |
2012-10-24 |
Cancer Rec Tech Ltd |
Pharmacologically active compounds
|
|
CN104703599A
(zh)
|
2012-09-14 |
2015-06-10 |
永恒生物科技公司 |
作为蛋白激酶抑制剂的氨基异喹啉衍生物
|
|
WO2014123900A1
(en)
|
2013-02-05 |
2014-08-14 |
Sirenas Marine Discovery |
Anti-cancer and anti-hiv compounds
|
|
EP3016946B1
(en)
|
2013-07-03 |
2022-10-12 |
Karyopharm Therapeutics Inc. |
Substituted benzofuranyl and benzoxazolyl compounds and pharmaceutical uses thereof
|
|
WO2016014674A1
(en)
|
2014-07-22 |
2016-01-28 |
University Of Maryland, College Park |
Linked diaryl compounds with anticancer properties and methods of using the same
|
|
GB201416754D0
(en)
|
2014-09-23 |
2014-11-05 |
Mission Therapeutics Ltd |
Novel compounds
|
|
RS61919B1
(sr)
*
|
2015-06-25 |
2021-06-30 |
Univ Health Network |
Inhibitori hpk1 i postupci za njihovo korišćenje
|
|
CA3002801A1
(en)
|
2015-10-20 |
2017-04-27 |
Axovant Sciences Gmbh |
Aminoisoxazoline compounds as agonists of alpha7-nicotinic acetylcholine receptors
|
|
EP3394044A1
(en)
|
2015-12-17 |
2018-10-31 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
|
CN107163022B
(zh)
|
2016-03-07 |
2021-07-16 |
上海如絮生物科技有限公司 |
一种异喹啉类化合物、其中间体、制备方法和应用
|
|
KR102408800B1
(ko)
|
2016-03-07 |
2022-06-13 |
머크 샤프 앤드 돔 코포레이션 |
비시클릭 아릴 모노박탐 화합물 및 박테리아 감염의 치료를 위한 그의 사용 방법
|
|
GB201604647D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
CN107266421B
(zh)
|
2016-04-08 |
2020-12-04 |
正大天晴药业集团股份有限公司 |
取代的苯并咪唑类衍生物
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
AR108326A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
UA125650C2
(uk)
*
|
2016-09-09 |
2022-05-11 |
Інсайт Корпорейшн |
Регулятори нрk1 на основі похідних піразолопіридину та їх застосування для лікування раку
|
|
US10280164B2
(en)
*
|
2016-09-09 |
2019-05-07 |
Incyte Corporation |
Pyrazolopyridone compounds and uses thereof
|
|
TWI771327B
(zh)
|
2016-10-05 |
2022-07-21 |
英商使命醫療公司 |
新穎化合物
|
|
US11180482B2
(en)
*
|
2016-11-30 |
2021-11-23 |
Ariad Pharmaceuticals, Inc. |
Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors
|
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
|
CN110214012B
(zh)
|
2017-01-20 |
2023-05-09 |
艾库斯生物科学有限公司 |
用于治疗癌症相关疾病的唑嘧啶
|
|
JP6453507B2
(ja)
|
2017-03-30 |
2019-01-16 |
アムジエン・インコーポレーテツド |
Ｍｃｌ−１タンパク質を阻害する化合物
|
|
AR111307A1
(es)
|
2017-03-30 |
2019-06-26 |
Takeda Pharmaceuticals Co |
Derivados de 1,2-dihidroespiro[ciclohexan-1,3-indol] o 1,2-dihidroespiro[ciclohexan-1,3-pirrolo[3,2-b]piridina] como inhibidores de hexakisfosfato quinasa
|
|
RU2019133646A
(ru)
*
|
2017-03-30 |
2021-04-30 |
Ф. Хоффманн-Ля Рош Аг |
Изохинолины в качестве ингибиторов hpk1
|
|
IL271149B2
(en)
|
2017-06-14 |
2024-05-01 |
Trevena Inc |
Compounds for modulating s1p1 activity and methods of using the same
|
|
US10604514B2
(en)
|
2017-10-19 |
2020-03-31 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
|
US10653688B2
(en)
|
2017-10-27 |
2020-05-19 |
Samumed, Llc |
6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
|
CN111836802A
(zh)
|
2018-02-12 |
2020-10-27 |
拜耳公司 |
杀真菌的*二唑
|
|
CN112601584A
(zh)
|
2018-07-24 |
2021-04-02 |
豪夫迈·罗氏有限公司 |
异喹啉化合物及其用途
|
|
TW202024053A
(zh)
|
2018-10-02 |
2020-07-01 |
美商建南德克公司 |
異喹啉化合物及其用途
|
|
US11612606B2
(en)
|
2018-10-03 |
2023-03-28 |
Genentech, Inc. |
8-aminoisoquinoline compounds and uses thereof
|
|
CN113166062A
(zh)
|
2018-10-03 |
2021-07-23 |
豪夫迈·罗氏有限公司 |
8-氨基异喹啉化合物及其用途
|